Russia will continue to increase share of domestic drugs and active ingredients

The Russian government plans to take additional measures to further increase the share of domestic drugs in the local market, as pressure from the West on the country and its pharmaceutical sector is growing.

This will involve the establishment of new domestic large-scale facilities that will focus on the production of both drugs and active pharmaceutical ingredients (APIs), reports The Pharma Letter’s local correspondent.

At least three large-scale pharmaceutical plants have been recently commissioned in the Russian cities of Kaliningrad, Saransk and St Petersburg via video conference. The government hopes that will contribute to the reduction of Russia’s dependence on drug imports.